.png){kind=icon}
.png){kind=icon}
Return
HIV drug resistance and treatment success in the Republic of Congo: Implications for optimized treatment
.png){kind=icon}
OA
AI
D
A
J
A
D
C
F
C
I
F
D
H
F
D
E
F
C
DOI：10.1111/hiv.70261.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Increasing rates of HIV-1 drug resistance (HIVDR) threaten the effectiveness of antiretroviral therapy (ART) programmes in sub-Saharan Africa, particularly among children, adolescents and young adults, who face limited treatment options. The Republic of Congo (ROC) lacks comprehensive national data on HIVDR in these vulnerable populations. The study aimed to determine the proportion of virologically unsuppressed young individuals receiving ART in ROC and to characterize the prevalence and patterns of HIVDR.
Keywords:
ART
drug resistance
HIV
Republic of Congo
sub-Sahara Africa
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.2
Papers:
301
Citations:
3.0K
View more organizations